RYTM
NASDAQ · Biotechnology
Rhythm Pharmaceuticals Inc
$107.55
+1.36 (+1.28%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-4.44%
1Y
+72.66%
YTD
+2.42%
Open$107.56
Previous Close$106.19
Day High$111.13
Day Low$106.62
52W High$122.20
52W Low$60.70
Volume—
Avg Volume982.2K
Market Cap6.64B
P/E Ratio—
EPS$-3.06
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$105.86
Above
SMA 200
$92.90
Above
RSI (14)
49.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-6.0% upside
Current
$107.55
$107.55
Target
$101.09
$101.09
$80.78
$101.09 avg
$123.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 200.29M | 975.71M | 873.25M |
| Net Income | -207,454,385 | -22,144,056 | -23,253,892 |
| Profit Margin | -103.6% | -2.3% | -2.7% |
| EBITDA | -201,267,245 | -26,213,634 | -24,112,007 |
| Free Cash Flow | — | -20,824,615 | -25,629,049 |
| Rev Growth | +100.2% | -2.7% | +8.2% |
| Debt/Equity | 0.40 | 0.40 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |